Museveni applauds Dr. Magoola for securing U.S Patent for Cancer treatment
Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune the expression of genes across numerous biological pathways.
DEI Biopharma
Dei BioPharma Founder Dr. Magoola wins prestigious Molecular Biologist Award for his mRNA cutting edge vaccines research
Dr. Matthias Magoola Recognized at International Molecular Biologist Awards for Vaccine Research KAMPALA – Recognition for Groundbreaking Work in mRNA and Therapeutic Proteins Dr. Matthias Magoola, Founder and Managing Director...
Parliament’s Health Committee urges Dei BioPharma to save Uganda from emerging tropical diseases
MPs Urge Dei Biopharma to Accelerate Production of Life-Saving Medicines KAMPALA, September 29, 2024 – Members of Parliament on the Health Committee have urged Dei Biopharma Vaccines Manufacturing Plant to...
Opposition MPs impressed by progress at Dei BioPharma’s manufacturing plant
Opposition Leader Joel Ssenyonyi Visits Dei BioPharma Facility in Matugga MATUGGA, September 19, 2024 – The sun shone brightly over the Dei BioPharma drugs and vaccines manufacturing facility, casting a...
Dei BioPharma wins top Africa accolade
KAMPALA – Dei BioPharma Wins Best Pharma Company at African Excellence Awards Dei BioPharma, Uganda’s first research-based biotechnology and pharmaceuticals firm, has been named the Best Pharma Company at this...
Dei Biopharma gets NDA clearance for drug manufacturing
The National Drug Authority (NDA) has granted Dei Biopharma Limited a landmark license to manufacture drugs at its Matugga premises. This certification marks a major achievement for the company, allowing...